Learn More
Invitrogen™ PIK3CA/PIK3R1 (p110 alpha/p85 alpha) Recombinant Human Protein
PIK3CA (p110 alpha) is known to be involved in the PI 3-kinase/AKT signaling pathway.
Marque: Invitrogen™ PV4788
Code nomenclature Nacres: NA.28
Informations supplémentaires : Poids : 0.50000kg
Description
PIK3CA (p110 alpha) is known to be involved in the PI 3-kinase⁄AKT signaling pathway, which plays an important role in regulating cell growth and apoptosis. PIK3CA is coexpressed and copurified with the regulatory subunit PI3KR1.Spécification
NP_003209.2 ⁄ NP_852664.1 | |
128.4⁄83.6 kDa | |
PIK3CA/PIK3R1 (p110 alpha/p85 alpha), PI3 Kinase alpha | |
Yes | |
Biochemical binding/kinetic, Biochemical ADP accumulation | |
Dry Ice | |
His (N-Terminal)⁄None | |
phosphoinositide-3-kinase, catalytic, alpha polypeptide | |
Kinases & Inhibitors | |
Liquid | |
Kinase Assay | |
Signal Transduction |
5290 | |
20 µg | |
PI3 Kinase Family | |
His Tag | |
Lipid Kinases | |
Adapta™ | |
PIK3CA/PIK3R1 | |
Baculovirus | |
Full Length, Recombinant | |
Lipid Kinases | |
Human |